HRT FINANCIAL LP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q2 2023$6,078
-99.6%
322,121
-10.9%
0.06%
+200.0%
Q3 2022$1,727,000
+444.8%
361,353
+745.6%
0.02%
+850.0%
Q4 2021$317,000
-71.6%
42,731
-78.3%
0.00%
-71.4%
Q3 2021$1,117,000
+167.9%
197,137
+282.2%
0.01%
+75.0%
Q1 2021$417,000
+101.4%
51,578
-46.0%
0.00%
-69.2%
Q2 2019$207,00095,5050.01%
Other shareholders
IMMUNOGEN INC shareholders Q4 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders